Interface Selection for Adaptive Servo Ventilation

Recruiting N/A Interventional Study
Central Sleep Apnea ASV
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Interventional
Purpose
Treatment
Participants needed
15 (estimated)
Sponsor
Universitaire Ziekenhuizen KU Leuven · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
The purpose of this study is to compare the effects of nasal and oronasal interfaces during ASV treatment on sleep efficiency and sleep architecture. Therefore, patients starting treatment with ASV, will be randomized between two groups. In the first group, patients will use a nasal interface during the first night and an oronasal interface during the second night. In the second group, patients wi…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Patients with central sleep apnea, not responding to treatment with CPAP * Indication for treatment with ASV Exclusion Criteria: * Patients \< 18 years old
Contacts

Dries Testelmans, MD, PhD

00 32 16 342522

dries.testelmans@uzleuven.be

CONTACT